WVCI to leverage Canopy's best-in-class AI across patient services to improve care between visits for patients and staff Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Willamette Valley Cancer Institute and Research Center (WVCI), a leader in advanced cancer treatments for over 25 years, to improve care between visits for both patients and staff.
New York, New York - Canopy, the leading Enterprise AI Platform for Oncology, today announced findings on the potential for EHR-integrated Remote Therapeutic Monitoring (RTM) to enable practices with medically integrated pharmacies (MIPs) to meet or exceed ASCO/NCODA standards for oral anti-cancer medication (OAM). While traditional approaches rely on phone-based OAM management, the Canopy RTM platform provides an easily scalable, technology-enhanced approach.
Author(s): James H. Essell, MD | Benjamin A. Derman, MD | Barry Brooks, MD | Gurjyot K. Doshi, MD | Michael Kolodziej, MD | Lavi Kwiatkowsky | Geoffrey Calkins | Mustafa S. Ascha, PhD, MS
New York, New York - Canopy, the first Remote Therapeutic Monitoring Platform for oncology, today announced findings from two studies examining the use of EHR-integrated Remote Therapeutic Monitoring (RTM) to capture real-world treatment experience for patients receiving a variety of melanoma and breast cancer treatment regimens. These studies demonstrate the ability of the Canopy Platform to surface regimen-specific symptom trends and highlight potential in-class differences.
New York, NY (February 6, 2025) – Canopy today announced that it has been named to the 2025 New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the 2025 New York Healthcare Innovation Report which analyzes the digital health sector's investment trends, challenges, and opportunities.
